Device Endo-Mechanical

Linx Reflux Management System

Payments companies reported to CMS as associated with Linx Reflux Management System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$231Kassociated payments (2023-2025)

1,041clinicians with associated payments

4companies reporting

By year

2023 $48K

2024 $100K

2025 $83K

Payments reported as associated with Linx Reflux Management System, per program year, as reported to CMS.

Who makes it

Medical Device Business Services, INC. $150K associated with Linx Reflux Management System (2023-2025)
Ethicon US, LLC $80K associated with Linx Reflux Management System (2023-2025)
Ethicon Endo-Surgery INC. $926 associated with Linx Reflux Management System (2023-2025)
Ethicon INC. $82.94 associated with Linx Reflux Management System (2023-2025)

Specialties most often involved

Surgery $168K

Family $17K

Physician Assistant $9,511

Gastroenterology (Internal Medicine) $8,978

Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,362

Family Medicine $2,100

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Linx Reflux Management System

These are the largest totals companies reported as associated with Linx Reflux Management System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Carol Chow	Newport Beach, CA	Family	$12,473.08
John Lipham	Los Angeles, CA	Surgery	$12,155.29
Philip Woodworth	Lone Tree, CO	Surgery	$9,332.63
Richard Englehardt	San Antonio, TX	Surgery	$5,472.45
Reginald Bell	Lone Tree, CO	Surgery	$4,900.16
Elwood Martin	Mansfield, OH	Surgery	$4,300.32
Lindsey Sharp	Raleigh, NC	Surgery	$3,231.69
Mark Hausmann	Baton Rouge, LA	Surgery	$3,161.79
Leena Khaitan	Cleveland, OH	Surgery	$2,389.79
Kristopher Johnson	Watertown, SD	Surgery	$2,074.80

Prescribed Linx Reflux Management System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.